cimetidine, PD 0332334, organic cation transporter, OCT2, pharmacokinetics
Showing 1 - 25 of >10,000
COPD Trial in Antwerp (CHF 5993 pMDI, Cimetidine plus CHF5993 pMDI)
Completed
- COPD
- CHF 5993 pMDI
- Cimetidine plus CHF5993 pMDI
-
Antwerp, BelgiumLife Science Services SGS Belgium NV
Oct 28, 2021
Chemo Induced Peripheral Neuropathy Trial (Omeprazole)
Not yet recruiting
- Chemotherapy Induced Peripheral Neuropathy
- (no location specified)
Jan 10, 2023
Interaction, Endogenous Biomarkers Trial in Spokane (MetFORMIN Oral Solution, Cimetidine 400 MG, Furosemide Oral Liquid Product)
Recruiting
- Interaction
- Endogenous Biomarkers
- MetFORMIN Oral Solution
- +3 more
-
Spokane, WashingtonWashington State University College of Pharmacy and Pharmaceutic
Sep 8, 2022
Healthy Participants Trial in Salt Lake City (DC-806, Midazolam, Repaglinide)
Not yet recruiting
- Healthy Participants
- DC-806
- +4 more
-
Salt Lake City, UtahICON Phase 1 Clinic
Oct 16, 2023
Malaria Trial in Belfast (Midazolam, Repaglinide, Dextromethorphan)
Completed
- Malaria
- Midazolam
- +7 more
-
Belfast, Northern Ireland, United KingdomNovartis Investigative Site
Nov 2, 2022
Pharmacokinetic Study in Healthy Volunteers Trial (Berberine)
Not yet recruiting
- Pharmacokinetic Study in Healthy Volunteers
- Berberine
- (no location specified)
May 4, 2023
ERCC1 and OCT2 on Occurrence and Severity of Cisplatin-induced
Not yet recruiting
- Cisplatin Adverse Reaction
- ERCC1
- OCT2
-
Cairo, EgyptFaculty of medicine, Ain Shams University
Feb 9, 2022
Pharmacokinetic Study in Healthy Volunteers Trial in Greifswald (Berberine)
Not yet recruiting
- Pharmacokinetic Study in Healthy Volunteers
- Berberine
-
Greifswald, Mecklenburg-Vorpommern, GermanyUniversity Medicine Greifswald, Institute of Pharmacology
Jul 13, 2022
Lactation Trial in Seattle (Cimetidine 200 MG)
Recruiting
- Lactation
- Cimetidine 200 MG
-
Seattle, WashingtonUniversity of Washington
Sep 20, 2023
Neonatal Infection Trial in Aurora (Amoxicillin, Cephalexin)
Enrolling by invitation
- Neonatal Infection
-
Aurora, ColoradoChildren's Hospital Colorado
Nov 2, 2022
Cisplatin Adverse Reaction Trial in Cairo (Rosuvastatin 10mg)
Recruiting
- Cisplatin Adverse Reaction
- Rosuvastatin 10mg
-
Cairo, EgyptKasr El-Aini Center of Radiation Oncology and Nuclear Medicine
Jul 26, 2021
Atomoxetine PBPK-PD Clinical Study
Completed
- ADHD
- Atomoxetine Hydrochloride
-
Kansas City, MissouriChildren's Mercy Hospital and Clinics
Jun 20, 2022
Interaction, Adverse Herb-Drug, Diabetes, Type 2 Trial in Spokane (Midazolam Hcl 1Mg/Ml Inj, Goldenseal (Hydrastis canadensis))
Active, not recruiting
- Interaction, Adverse Herb-Drug
- Diabetes Mellitus, Type 2
- Midazolam Hcl 1Mg/Ml Inj
- Goldenseal (Hydrastis canadensis)
-
Spokane, WashingtonWashington State University College of Pharmacy and Pharmaceutic
Nov 18, 2022
Healthy Trial in Seoul (Metformin, Metformin + Nilotinib)
Completed
- Healthy
- Metformin
- Metformin + Nilotinib
-
Seoul, Guro-gu, Korea, Republic ofKorea University Guro Hospital
Nov 3, 2020
Immune System Disorder (Healthy Volunteers) Trial in Miami (Belumosudil, UGT1A1 victim drug, P-gp victim drug)
Completed
- Immune System Disorder (Healthy Volunteers)
- Belumosudil
- +3 more
-
Miami, FloridaInvestigational Site Number: 8400001
Apr 11, 2023
Acute Hyperkalemia, Oral Potassium Binders Trial in Orange (Polyethylene Glycol 3350, Sodium Polystyrene Sulfonate Oral
Recruiting
- Acute Hyperkalemia
- Oral Potassium Binders
- Polyethylene Glycol 3350
- +3 more
-
Orange, CaliforniaUniversity of California, Irvine Medical Center
Nov 2, 2022
Sickle Cell Disease Trial in San Antonio (Voxelotor, Bupropion, Repaglinide)
Recruiting
- Sickle Cell Disease
- Voxelotor
- +8 more
-
San Antonio, TexasICON Early Phase Services, LLC
Jul 31, 2023
Malignant Tumor Trial in Shanghai (PM8002)
Recruiting
- Malignant Neoplasm
-
Shanghai, Shanghai, ChinaShanghai Orient Hospital
Jun 25, 2023
Healthy Participants Trial in Glendale (AZD2389, Placebo)
Not yet recruiting
- Healthy Participants
- AZD2389
- Placebo
-
Glendale, CaliforniaResearch Site
Nov 14, 2023
Healthy Participants Trial in Glendale, Brooklyn (AZD4144 Part A, AZD4144 Part B, Placebo Part A)
Not yet recruiting
- Healthy Participants
- AZD4144 Part A
- +3 more
-
Glendale, California
- +1 more
Nov 3, 2023